Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature.

Source:http://linkedlifedata.com/resource/pubmed/id/15075093

Download in:

View as

General Info

PMID
15075093